Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Vaccine

• Publication date

  2010-08-23

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.vaccine.2010.06.100PMID 20637303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Baculovirus Dual Expression System-Based Malaria Vaccine Induces Strong Protection against Plasmodium berghei Sporozoite Challenge in Mice

  2009cited by this paper
• Malaria Ookinete Surface Protein-Based Vaccination via the Intranasal Route Completely Blocks Parasite Transmission in both Passive and Active Vaccination Regimens in a Rodent Model of Malaria Infection

  2009cited by this paper
• Baculovirus-Based Nasal Drop Vaccine Confers Complete Protection against Malaria by Natural Boosting of Vaccine-Induced Antibodies in Mice

  2009cited by this paper
• Safety and Immunogenicity of H5N1 Influenza Vaccine Based on Baculovirus Surface Display System of Bombyx mori

  2008cited by this paper
• Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

  2008cited by this paper
• Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.

  2008cited by this paper
• World Malaria Report, 2008.

  2008cited by this paper
• Murine Model for Assessment of Plasmodium falciparum Transmission-Blocking Vaccine Using Transgenic Plasmodium berghei Parasites Expressing the Target Antigen Pfs25

  2008cited by this paper
• Wheat Germ Cell-Free System-Based Production of Malaria Proteins for Discovery of Novel Vaccine Candidates

  2008cited by this paper
• The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.

  2007cited by this paper
• Nasal Immunization with a Malaria Transmission-Blocking Vaccine Candidate, Pfs25, Induces Complete Protective Immunity in Mice against Field Isolates of Plasmodium falciparum

  2005cited by this paper
• Involvement of the Toll-Like Receptor 9 Signaling Pathway in the Induction of Innate Immunity by Baculovirus

  2005cited by this paper
• Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.

  2005cited by this paper
• Quantitative Plasmodium sporozoite neutralization assay (TSNA).

  2004cited by this paper
• Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes.

  2003cited by this paper
• Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection.

  2003cited by this paper
• Molecular interactions between Plasmodium and its insect vectors

  2002cited by this paper
• Transmission-blocking vaccines.

  2002cited by this paper
• Current developments in malaria transmission-blocking vaccines

  2001cited by this paper
• Transmission blocking malaria vaccines.

  2001cited by this paper
• Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism.

  2001cited by this paper
• Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain.

  2001cited by this paper
• Immunization of Mice with DNA-Based Pfs25 Elicits Potent Malaria Transmission-Blocking Antibodies

  1999cited by this paper
• “Baculophage:” A new tool for protein display

  1995cited by this paper
• Malaria vaccine development

  1994cited by this paper
• A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice

  1993cited by this paper
• Malaria transmission-blocking vaccines.

  1992cited by this paper
• Analysis of immunity induced by the affinity-purified 21-kilodalton zygote-ookinete surface antigen of Plasmodium berghei

  1991cited by this paper
• Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria.

  1988cited by this paper
• Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins.

  1987cited by this paper
• Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito

  1985cited by this paper

• Malaria bivalent viral vectored vaccine protects against Plasmodium falciparum and vivax and blocks parasite transmission

  2025cites this paper
• Advances in transmission-blocking vaccines against Plasmodium falciparum and Plasmodium vivax

  2025cites this paper
• A novel ex vivo assay to evaluate functional effectiveness of Plasmodium vivax transmission blocking vaccine using Pvs25 transgenic P. berghei.

  2024cites this paper
• Plasmodium vivax vaccine: What is the best way to go?

  2023cites this paper
• Baculovirus Display of Peptides and Proteins for Medical Applications

  2023cites this paper
• Highly efficient protein expression of Plasmodium vivax surface antigen, Pvs25 by silkworm, Bombyx mori, and its biochemical analysis

  2022cites this paper
• A genetically modified Plasmodium berghei parasite as a surrogate for whole-sporozoite vaccination against P. vivax malaria

  2022cites this paper
• Highly efficient protein expression of Plasmodium vivax surface antigen, Pvs25, by silkworm and its biochemical analysis.

  2022cites this paper
• BacMam virus-based surface display for HCV E2 glycoprotein induces strong cross-neutralizing antibodies and cellular immune responses in vaccinated mice

  2021cites this paper
• How can we develop an effective subunit vaccine to achieve successful malaria eradication?

  2021cites this paper
• Plasmodium vivax transmission-blocking vaccines: Progress, challenges and innovation.

  2021cites this paper
• Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination

  2021cites this paper
• Induction of mucosal immunity against pathogens by using recombinant baculoviral vectors: Mechanisms, advantages, and limitations

  2020cites this paper
• Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites

  2019cites this paper
• Baculovirus-inducing fast-acting innate immunity kills Plasmodium liver stages

  2018cites this paper
• Baculovirus-Induced Fast-Acting Innate Immunity Kills Liver-Stage Plasmodium

  2018cites this paper
• Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development

  2018cites this paper
• Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity

  2018cites this paper
• Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model

  2018cites this paper
• Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate

  2017cites this paper
• The use of transgenic parasites in malaria vaccine research

  2017cites this paper
• Protective efficacy of an IL‐12‐expressing baculoviral malaria vaccine

  2017cites this paper
• DAF-shielded baculovirus-vectored vaccine enhances protection against malaria sporozoite challenge in mice

  2017cites this paper
• Development of a Plasmodium berghei transgenic parasite expressing the full-length Plasmodium vivax circumsporozoite VK247 protein for testing vaccine efficacy in a murine model

  2016cites this paper
• Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection.

  2016cites this paper
• Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax

  2016cites this paper
• Identification of three ookinete-specific genes and evaluation of their transmission-blocking potentials in Plasmodium berghei.

  2016cites this paper
• Insect Pathology

  2016cites this paper
• Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax

  2016cites this paper
• The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro.

  2015cites this paper
• Protection against Amoebic Liver Abscess in Hamster by Intramuscular Immunization with an Autographa californica Baculovirus Driving the Expression of the Gal-Lectin LC3 Fragment

  2015cites this paper
• The march toward malaria vaccines.

  2015cites this paper
• Role of plasmodium translationally repressed gene products in malaria transmission

  2015cites this paper
• Development of malaria transmission-blocking vaccines: from concept to product.

  2015cites this paper
• Recombinant Pvs48/45 Antigen Expressed in E. coli Generates Antibodies that Block Malaria Transmission in Anopheles albimanus Mosquitoes

  2015cites this paper
• The March Toward Malaria Vaccines.

  2015cites this paper
• Baculovirus-Vectored Multistage Plasmodium vivax Vaccine Induces Both Protective and Transmission-Blocking Immunities against Transgenic Rodent Malaria Parasites

  2014cites this paper
• Update on baculovirus as an expression and/or delivery vehicle for vaccine antigens

  2014cites this paper
• Protective and Transmission-blocking Immunities against Transgenic Rodent 2

  2014cites this paper
• Assessing transmission blockade in Plasmodium spp.

  2013cites this paper
• Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge.

  2013cites this paper
• Host Responses in Human Skin After Conventional Intradermal Injection or Microneedle Administration of Virus‐Like‐Particle Influenza Vaccine

  2013cites this paper
• Protective Efficacy of Baculovirus Dual Expression System Vaccine Expressing Plasmodium falciparum Circumsporozoite Protein

  2013cites this paper
• Scope and Basic Principles of Insect Pathology

  2012cites this paper
• Baculovirus as a gene delivery vector: Recent understandings of molecular alterations in transduced cells and latest applications

  2011cites this paper
• Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination

  2011cites this paper
• Quality control and analytical methods for baculovirus-based products.

  2011cites this paper
• Mucosal Delivery of ACNPV Baculovirus Driving Expression of the Gal-Lectin LC3 Fragment Confers Protection against Amoebic Liver Abscess in Hamster

  2011cites this paper
• A Viral Vectored Prime-Boost Immunization Regime Targeting the Malaria Pfs25 Antigen Induces Transmission-Blocking Activity

  2011influential citation
• Baculovirus Capsid Display Potentiates OVA Cytotoxic and Innate Immune Responses

  2011cites this paper
• Genetic diversity of transmission-blocking vaccine candidates Pvs25 and Pvs28 in Plasmodium vivax isolates from Yunnan Province, China

  2011cites this paper
• Application of baculovirus-insect cell expression system for human therapy.

  2011cites this paper
• Plasmodium berghei Circumvents Immune Responses Induced by Merozoite Surface Protein 1- and Apical Membrane Antigen 1-Based Vaccines

  2010cites this paper
• Isolation and full-length sequence analysis of Armigeres subalbatus totivirus, the first totivirus isolate from mosquitoes representing a proposed novel genus (Artivirus) of the family Totiviridae.

  2010cites this paper
• A genetically modi fi ed Plasmodium berghei parasite as a surrogate for whole-sporozoite vaccination against P. vivax malaria

  year unknowncites this paper